| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6002705 | Thrombosis Research | 2013 | 9 Pages | 
Abstract
												Oligoanion-modified tPA could be used for targeted/triggered delivery where its enzymatic activity could be masked by HSA-protamine conjugate and successfully regenerated by therapeutic dose of heparin.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Shahriar Absar, Suna Choi, Fakhrul Ahsan, Everardo Cobos, Victor C. Yang, Young M. Kwon, 
											